TCL Archive Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer June 27, 2014
TCL Archive Advisors Approve $50 Million NCI Effort To Attack Cancer On a Molecular Level July 2, 1999